SODIUM VALPROATE AND METYRAPONE FOR PITUITARY-DEPENDENT CUSHING'S DISEASE
- 15 September 1984
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 324 (8403) , 640
- https://doi.org/10.1016/s0140-6736(84)90631-7
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Prolonged remission of a case of Cushing's disease following cessation of cyproheptadine therapyActa Endocrinologica, 1983
- Effect of cyproheptadine, desmethylcyproheptadine, γ-amino-butyric acid and sodium valproate on adrenocorticotrophin secretion by cultured pituitary tumour cells from three patients with Nelson's syndromeJournal of Endocrinology, 1983
- Physiopathology of Cushing's DiseaseEndocrine Reviews, 1983
- ³-Aminobutyric Acid- and Benzodiazepine-Binding Sites in Human Anterior Pituitary TissueJournal of Clinical Endocrinology & Metabolism, 1982
- Adrenocorticotropin-Secreting Pituitary Adenomas Originate from the Anterior or the Intermediate Lobe in Cushing's Disease: Differences in the Regulation of Hormone SecretionJournal of Clinical Endocrinology & Metabolism, 1982
- EFFECTS OF VALPROIC ACID, NALOXONE AND HYDROCORTISONE IN NELSON'S SYNDROME AND CUSHING'S DISEASEClinical Endocrinology, 1981
- EFFECT OF TREATMENT WITH SODIUM VALPROATE AND DIAZEPAM ON PLASMA CORTICOTROPIN IN NELSON'S SYNDROMEThe Lancet, 1981